IP Library Granted Patent US 7,772,428
Granted Patent B2
US 7,772,428 · App. 12/108,822 · Granted Aug 10, 2010

Creatine hydroxycitric acids salts and methods for their production and use in individuals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,772,428
App. No.
12/108,822
Granted
Aug 10, 2010
Kind
B2
Abstract

Methods of production for Tricreatine Hydroxycitrate are disclosed. Tricreatine hydroxycitrate can be used as supplemental dietary ingredient for the purposes of reducing adiposity, suppression of appetite, improvement of muscle and exercise performance and recovery. The salts are useful in the dietetic, food supplement and food industries.

Claims (21)

1. A supplemental dietary composition for oral use comprising creatine hydroxycitric acid in the form of a hydrosoluble salt of creatine and hydroxycitrate, wherein said composition is in the form of a capsule, tablet or a caplet.

2. The supplemental dietary composition of claim 1 , wherein the salt has a molecular weight of 599.55.

3. The supplemental dietary composition of claim 1 , wherein the salt has a melting point of about 290° C.

4. A method for at least one or promoting increased muscle and exercise performance and improving exercise recovery in individuals; the method including the step of consuming the supplemental dietary composition of claim 1 .

5. The supplemental dietary composition of claim 1 , wherein the composition additionally comprises one or more of the following dietary ingredients:

whey protein, casein, alpha lipoic acid, carbohydrates, free-form amino acids and salts, trivalent chromium and its organic salts and chelates, vitamins and minerals, Camellia sinensis leaf and its polyphenolic extracts, caffeine and other thermogenics, bioflavonoids, condensed tannins, oligomeric proanthocyanidins, American and/or Korean ginseng and their extracts, konjac glucomannan, creatinol, creatinol O-phosphate, creatinol sulfate, policosanol, and adaptogenic herbs and remedies.

6. The supplemental dietary composition of claim 5 comprising alpha lipoic acid.

7. The supplemental dietary composition of claim 5 comprising free-form amino acids and salts.

8. The supplemental dietary composition of claim 5 comprising trivalent chromium and its organic salts and chelates.

9. The supplemental dietary composition of claim 5 comprising vitamins and minerals.

10. The supplemental dietary composition of claim 5 comprising Camellia sinensis leaf and its polyphenolic extracts.

11. The supplemental dietary composition of claim 5 comprising caffeine and other thermogenics.

12. The supplemental dietary composition of claim 5 comprising bioflavonoids.

13. The supplemental dietary composition of claim 5 comprising American and/or Korean ginseng and their extracts.

14. The supplemental dietary composition of claim 5 comprising konjac glucomannan.

15. The supplemental dietary composition of claim 5 comprising creatinol.

16. The supplemental dietary composition of claim 5 comprising creatinol O-phosphate.

17. The supplemental dietary composition of claim 5 comprising creatinol sulfate.

18. The supplemental dietary composition of claim 5 comprising policosanol.

19. The supplemental dietary composition of claim 5 comprising adaptogenic herbs and remedies.

20. The supplemental dietary composition of claim 5 comprising alpha lipoic acid, free-form amino acids and salts, vitamins and minerals, caffeine and other thermogenics, and American and/or Korean ginseng and their extracts.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded May 29, 2026
From: ROYAL BANK OF CANADA
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 075647/0267 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SERIAL NUMBER OF PATENT NUMBER 7,645,812 TO 7,465,812 PREVIOUSLY RECORDED AT REEL: 059662 FRAME: 0958. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 26, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059793/0777 →
SECURITY INTEREST Recorded Apr 21, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059662/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2016
From: BAGCHI, DEBASIS; DOHERTY, JOHN; APONG, PHIL; JOSHI, VAISHALI; PETERS, JASON
To: NORTHERN INNOVATIONS HOLDING CORP
Reel/Frame 040283/0769 →
CHANGE OF NAME Recorded Oct 6, 2016
From: 2462096 ONTARIO LIMITED
To: NORTHERN INNOVATIONS HOLDING CORP
Reel/Frame 040246/0841 →
CHANGE OF NAME Recorded Oct 6, 2016
From: 2508304 ONTARIO LIMIITED
To: NORTHERN INNOVATIONS HOLDING CORP
Reel/Frame 040247/0040 →
CHANGE OF NAME Recorded Oct 6, 2016
From: NORTHERN INNOVATIONS HOLDING CORP
To: OLD NORTHERN INNOVATIONS CORP
Reel/Frame 040246/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2016
From: OLD NORTHERN INNOVATIONS CORP
To: 2462096 ONTARIO LIMITED
Reel/Frame 039955/0136 →
MERGER Recorded Oct 6, 2016
From: NORTHERN INNOVATIONS HOLDING CORP
To: OLD NORTHERN INNOVATIONS CORP
Reel/Frame 039955/0483 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2016
From: OLD NORTHERN INNOVATIONS CORP
To: 2508304 ONTARIO LIMIITED
Reel/Frame 039955/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2012
From: NEW CELL FORMULATIONS, LTD.
To: NORTHERN INNOVATIONS AND FORMULATIONS CORP
Reel/Frame 028301/0564 →
MERGER Recorded Jun 1, 2012
From: NORTHERN INNOVATIONS AND FORMULATIONS CORP
To: NORTHERN INNOVATIONS HOLDING CORP
Reel/Frame 028301/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2008
From: GARDINER, PAUL, MR; HEUER, MARVIN, DR; MOLINO, MICHELE, MR
To: NEW CELL FORMULATIONS LTD
Reel/Frame 020850/0915 →